February 20-22, 2020 | New York Hilton Midtown, NY

Integrative and Comprehensive Approach to Inflammatory Bowel Disease

Feb 21 2019
11:15 am - 12:15 pm
Learning Annex
Ronald Hoffman MD, CNS, FACAM

The incidence of inflammatory bowel disease (IBD) — comprising Crohn’s Disease and ulcerative colitis — is soaring in Western countries. How do modern lifestyles and medical practices contribute to its incidence? Is there a stress component? What is the current “standard of care” for IBD, and what are the limitations of drug therapies? What is the rationale for incorporating natural interventions—diet, supplements, and innovative strategies—for IBD? What is the current thinking about the causation of IBD, and how does it validate wholistic correctives? What nutritional deficiencies are commonly seen in IBD sufferers? What nutritional support strategies have been demonstrated to support disease amelioration? Why is the current practice of oral iron supplementation for the anemia commonly seen in IBD counterproductive? What role for the Specific Carbohydrate Diet (SCD)? What are its potential drawbacks? What other dietary considerations apply to IBD? Which nutraceuticals have documented efficacy in IBD? What role for probiotics? Does the “Yeast Connection” offer actionable insights on IBD? Could cannabinoids be therapeutic? Are testosterone, DHEA, or GH beneficial? Is there a potential for fecal transplants to ameliorate IBD? Is low-dose naltrexone (LDN) a plausible option? Case studies will illustrate opportunities and challenges in the integrative management of IBD.

Learning Objectives:
  1. Participants will be able to explain why modern diet and lifestyle contribute to the rising incidence of inflammatory bowel disease.
  2. Participants will be able to identify which nutritional deficiencies characterize IBD.
  3. Participants will be able to discuss the limits of effectiveness of current standard of care for IBD, along with the evidence-based nutraceuticals and dietary strategies for IBD.
  4. Participants will be able to illustrate the potential roles of innovative strategies for IBD such as cannabinoids, LDN, fecal transfer, hormone support.
Track Name: IHS 2019
Session Date: Feb 21 2019 11:15 am – 12:15 pm
© Diversified Communications. All rights reserved.